Literature DB >> 10775623

A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.

E Kotsopoulou1, V N Kim, A J Kingsman, S M Kingsman, K A Mitrophanous.   

Abstract

The human immunodeficiency virus (HIV) genome is AU rich, and this imparts a codon bias that is quite different from the one used by human genes. The codon usage is particularly marked for the gag, pol, and env genes. Interestingly, the expression of these genes is dependent on the presence of the Rev/Rev-responsive element (RRE) regulatory system, even in contexts other than the HIV genome. The Rev dependency has been explained in part by the presence of RNA instability sequences residing in these coding regions. The requirement for Rev also places a limitation on the development of HIV-based vectors, because of the requirement to provide an accessory factor. We have now synthesized a complete codon-optimized HIV-1 gag-pol gene. We show that expression levels are high and that expression is Rev independent. This effect is due to an increase in the amount of gag-pol mRNA. Provision of the RRE in cis did not lower protein or RNA levels or stimulate a Rev response. Furthermore we have used this synthetic gag-pol gene to produce HIV vectors that now lack all of the accessory proteins. These vectors should now be safer than murine leukemia virus-based vectors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775623      PMCID: PMC112007          DOI: 10.1128/jvi.74.10.4839-4852.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

Review 1.  Regulation of translation in eukaryotic systems.

Authors:  M Kozak
Journal:  Annu Rev Cell Biol       Date:  1992

2.  Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.

Authors:  S Schwartz; M Campbell; G Nasioulas; J Harrison; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes.

Authors:  M H Malim; B R Cullen
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

4.  Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.

Authors:  G Nasioulas; A S Zolotukhin; C Tabernero; L Solomin; C P Cunningham; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

5.  Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.

Authors:  A S Zolotukhin; A Valentin; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.

Authors:  J K Yee; A Miyanohara; P LaPorte; K Bouic; J C Burns; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.

Authors:  C Parolin; T Dorfman; G Palú; H Göttlinger; J Sodroski
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals.

Authors:  D W Brighty; M Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

9.  Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome.

Authors:  H S Olsen; A W Cochrane; C Rosen
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

10.  Translational frameshifting at the gag-pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells.

Authors:  M Cassan; N Delaunay; C Vaquero; J P Rousset
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more
  87 in total

1.  Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.

Authors:  M R Mautino; N Keiser; R A Morgan
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Role of ESCRT-I in retroviral budding.

Authors:  Juan Martin-Serrano; Trinity Zang; Paul D Bieniasz
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Novel transcript truncating function of Rap1p revealed by synthetic codon-optimized Ty1 retrotransposon.

Authors:  Robert M Yarrington; Sarah M Richardson; Cheng Ran Lisa Huang; Jef D Boeke
Journal:  Genetics       Date:  2011-11-30       Impact factor: 4.562

4.  Nuclear RNA export and packaging functions of HIV-1 Rev revisited.

Authors:  Maik Blissenbach; Bastian Grewe; Bianca Hoffmann; Sabine Brandt; Klaus Uberla
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

5.  Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies.

Authors:  Ying Poi Liu; Monique A Vink; Jan-Tinus Westerink; Eva Ramirez de Arellano; Pavlina Konstantinova; Olivier Ter Brake; Ben Berkhout
Journal:  RNA       Date:  2010-05-24       Impact factor: 4.942

Review 6.  Immunization delivered by lentiviral vectors for cancer and infectious diseases.

Authors:  Biliang Hu; April Tai; Pin Wang
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

7.  Patterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication.

Authors:  Andrea Galli; Mary Kearney; Olga A Nikolaitchik; Sloane Yu; Mario P S Chin; Frank Maldarelli; John M Coffin; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

8.  Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry.

Authors:  Fedde Groot; Rogier W Sanders; Olivier ter Brake; Kamran Nazmi; Enno C I Veerman; Jan G M Bolscher; Ben Berkhout
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 9.  Codon-optimized reading frames facilitate high-level expression of the HIV-1 minor proteins.

Authors:  D S Anson; K R Dunning
Journal:  Mol Biotechnol       Date:  2005-09       Impact factor: 2.695

10.  Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.

Authors:  L Deml; A Bojak; S Steck; M Graf; J Wild; R Schirmbeck; H Wolf; R Wagner
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.